A Review on Therapeutic Management of Chronic Hepatitis B Infection

Archives of Clinical Gastroenterology

Review Article

Abstract
The current therapeutic goal in the management of chronic hepatitis B (CHB) infection is to persistently suppress hepatitis B virus (HBV) replication and prevent its progression to liver failure and the development of hepatocellular carcinoma (HCC). At present, the therapeutic strategies for CHB includes either a short course of pegylated-interferon-alfa (PEG-IFNa) and/or a long term course of nucleos(t)ide analogues (NA’s). NA’s are more preferable to PEG-IFNa, majorly for its easier route of administration and excellent tolerance and safety profiles.

http://www.peertechz.com/Clinical-Gastroenterology/pdf/ACG-1-106.pdf


Comments

Popular posts from this blog

Case Report: Reynolds Syndrome

Successful treatment of Budd- Chiari Syndrome with Percutaneous transluminal Balloon Angioplasty

Apparent Digestibility and Utilization of Protein and Phosphorus in diets of incorporated with Sprouted Sorghum, Phytase and Protease Enzymes for African Catfi sh (Clarias gariepinus)